{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Neurotransmitter disorders",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_phenelzine",
          "name": "Phenelzine"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_selegiline",
          "name": "Selegiline"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_fluoxetine",
          "name": "Fluoxetine"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_paroxetine",
          "name": "Paroxetine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_bupropion",
          "name": "Bupropion"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_clomipramine",
          "name": "Clomipramine"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_sertraline",
          "name": "Sertraline"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_venlafaxine",
          "name": "Venlafaxine"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_thioridazine",
          "name": "Thioridazine"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_risperidone",
          "name": "Risperidone"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_tranylcypromine",
          "name": "Tranylcypromine"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_citalopram",
          "name": "Citalopram"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_t1",
          "type": "Target",
          "label": "Monoamine Oxidase A (MAO-A)",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_t2",
          "type": "Target",
          "label": "Serotonin Transporter",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_t3",
          "type": "Target",
          "label": "Norepinephrine Transporter",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_d1",
          "type": "Disease",
          "label": "Depression",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_d2",
          "type": "Disease",
          "label": "Anxiety Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_p1",
          "type": "Pathway",
          "label": "Monoamine Signaling Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_p2",
          "type": "Pathway",
          "label": "Serotonin Reuptake Inhibition Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_phenelzine",
          "target": "n_t1",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知作用于 MAO-A"
        },
        {
          "source": "drug_selegiline",
          "target": "n_t1",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通过抑制 MAO-A 提升单胺水平"
        },
        {
          "source": "drug_fluoxetine",
          "target": "n_t2",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已知选择性抑制5-HT再摄取"
        },
        {
          "source": "drug_paroxetine",
          "target": "n_t2",
          "relation": "acts_on",
          "weight": 0.88,
          "agent": "Proponent",
          "rationale": "选择性5-HT再摄取抑制"
        },
        {
          "source": "drug_bupropion",
          "target": "n_t3",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "影响去甲肾上腺素和多巴胺转运"
        },
        {
          "source": "n_t1",
          "target": "n_p1",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "与单胺信号通路相关"
        },
        {
          "source": "n_t2",
          "target": "n_p2",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "影响5-HT的再摄取"
        },
        {
          "source": "n_p1",
          "target": "n_d1",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知影响抑郁症相关"
        },
        {
          "source": "n_p2",
          "target": "n_d2",
          "relation": "causes",
          "weight": 0.76,
          "agent": "Proponent",
          "rationale": "已知与焦虑症相关"
        },
        {
          "source": "drug_phenelzine",
          "target": "H1",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "通过MAO-A作用支持假设"
        },
        {
          "source": "drug_selegiline",
          "target": "H2",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通过MAO抑制支持假设"
        },
        {
          "source": "drug_fluoxetine",
          "target": "H3",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "通过选择性抑制5-HT支持假设"
        },
        {
          "source": "drug_paroxetine",
          "target": "H4",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "选择性抑制作用支持假设"
        },
        {
          "source": "drug_bupropion",
          "target": "H5",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "多巴胺及去甲肾上腺素机制支持假设"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "药物通过靶向单胺信号通路影响抑郁症及焦虑症相关机制",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "药物具有足够的靶向生物可及性以发挥疗效"
    ],
    "uncertainties": [
      "不同患者的反应性可能因个体差异而异（需深入研究）"
    ],
    "next_focus_for_pi": [
      "考虑进一步探索其他路径或机制"
    ]
  }
}